Over the past several decades, treatment for a variety of conditions has begun to shift from a “one size fits all” approach to a more personalized one: the right dose of the right drug for the right patient at the right time. As a result, patients can more often be matched to the best drug for their genetic makeup or the exact subcategory of their disease.
This is similar to the amazing new medical treatments and techniques discussed by Eric Topol in “The Creative Destruction of Medicine.” (Check out the book recommendations on the right).
One issue that may potentially hold this back is regulations. Our medical regulatory system is not designed to deal with personalized medical treatment.